logo
episode-header-image
May 2023
19m 55s

Drugmakers Face Ongoing Vaccine Hesitanc...

The Wall Street Journal
About this episode

P.M. Edition for May 31. The FDA approves Pfizer’s vaccine for RSV, a deadly respiratory virus. But as Wall Street Journal health business editor Jonathan Rockoff reports, companies are preparing to introduce the shots after resistance to vaccination reached new highs during the pandemic. Annmarie Fertoli hosts.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Up next
Yesterday
What Linda Yaccarino’s Departure Means for X
P.M. Edition for July 9. After about two years at the helm of Elon Musk’s social-media platform, Linda Yaccarino has stepped down as the CEO of X. WSJ advertising editor Suzanne Vranica discusses what that means for X, which recently merged with Musk’s artificial intelligence com ... Show More
13m 6s
Yesterday
Trump Calls Out Putin Over Ukraine
A.M. Edition for July 9. As Russia intensifies its assault on Ukraine, President Trump is losing his patience with Vladimir Putin. Journal correspondent Matthew Luxmoore says the president is now considering sending an additional patriot missile system to Kyiv. Plus, the Trump ad ... Show More
15m 11s
Jul 8
Copper Prices Hit Record High as Trump Unveils 50% Tariffs
P.M. Edition for July 8. During a cabinet meeting today, President Trump announced a 50% tariff on copper and threatened the European Union with steep tariffs if it doesn't reach a trade deal with the U.S. WSJ reporter Kim Mackrael says the EU’s member states are split as to how ... Show More
13m 23s
Recommended Episodes
Dec 2020
Vaccine hesitancy, the next pandemic hurdle
As the Pfizer-BioNTech vaccine rolls out across the country, and other vaccines await imminent regulatory approval, many public health experts are focusing on the issue of vaccine hesitancy. Canada's Chief Public Health Officer Dr. Theresa Tam has spoken out about the "moveable m ... Show More
31m 47s
Nov 2020
A Vaccine Breakthrough
It’s a dark time in the struggle with the coronavirus, particularly in the United States, where infections and hospitalizations have surged.But amid the gloom comes some light: A trial by the drug maker Pfizer has returned preliminary results suggesting that its vaccine is 90 per ... Show More
24m 29s
Dec 2020
Race for the Vaccine
On the same day the COVID-19 death toll surpassed 300,000 in the United States, the first vaccines are being administered, finally giving millions of Americans hope for a better future and a return to normalcy. We explore how officials expect to deliver a safe and effective vacci ... Show More
39m 42s
Jul 2020
The Vaccine Trust Problem
Public health officials and private researchers have vowed to develop a coronavirus vaccine in record time. But could that rush backfire? Guest: Jan Hoffman, a health reporter for The New York Times. For more information on today’s episode, visit nytimes.com/thedaily Background r ... Show More
27m 45s
Dec 2020
Why Did the U.S. Turn Down Vaccine Doses?
From the start of the pandemic, the Trump administration said it was committed to ordering and stockpiling enough potential vaccine doses to end the outbreak in the United States as quickly as possible.But new reporting from The Times has revealed that Pfizer, the maker of the fi ... Show More
25m 38s
Nov 2020
Moderna's chief medical officer on its blockbuster vaccine news
Moderna Therapeutics today reported a 94.5% efficacy for its COVID-19 vaccine, which needn't be stored at the same ultra-cold temperatures as does a similar vaccine developed by Pfizer. It also said short-term safety concerns, such as headaches and injection site soreness, self-r ... Show More
17m 46s
Jan 2021
Ex-CDC director Tom Frieden on the next COVID-19 vaccines
Americans fortunate enough to receive vaccines right now, outside of clinical trials, are getting ones made by either Pfizer or Moderna. But newly released data from Novavax and Johnson & Johnson suggests that more vaccines could be on the way. Dan digs into the news and why it m ... Show More
15m 44s
Nov 2022
A vaccine for RSV
A respiratory virus called RSV has a lot of kids in critical condition and hospitals overwhelmed. Vox public health reporter and epidemiologist Keren Landman explains newfound hope for a vaccine.This episode was produced by Victoria Chamberlin, edited by Matt Collette, fact-check ... Show More
27m 6s
Oct 2020
Operation Warp Speed's Moncef Slaoui on the new vaccine timeline
Pfizer today said it won't apply for an emergency use authorization for its COVID-19 vaccine until late November, all but guaranteeing that the FDA won't be asked to consider approval until after the election. Dan is joined by Moncef Slaoui, the White House's chief scientific adv ... Show More
13m 43s
May 2021
Biden administration on vaccine doses: Use it or lose it! Plus, should the U.S. share its vaccine doses with struggling countries?
The Biden administration is changing its vaccine distribution plan. Will it lead to more shots into arms?Should the U.S. ship more vaccine doses to struggling countries?A city in southern California is already planning on how to best distribute Pfizer vaccines for kids.The pandem ... Show More
23m 45s
Listen to millions of songs and podcasts on Anghami